Acasti Pharma, Inc.

Q4 2025 13F Holders

Symbol
ACST
CUSIP
00430K865
Type
Equity
Class
CL A
Num filings
1
Total reported value, excl. options
$0
Manager Report Date Value ($000) Shares Option Type